Shilpi Singh

University of Minnesota

H指数:21

被引数:2,236

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance

前馈miR-181d降解调控甲基鸟嘌呤甲基转移酶群体方差及替莫唑胺耐药性

Cell Reports

IF6.9

2025-11-100

OAAI

Variance in Methyl-guanine methyl transferase (MGMT) expression as a defining feature of intra-tumoral heterogeneity that contribute to acquired temozolomide resistance in glioblastoma

MGMT（甲基鸟嘌呤甲基转移酶）表达变异作为肿瘤内异质性的界定特征，其对胶质母细胞瘤获得性替莫唑胺耐药性的贡献。

NEURO-ONCOLOGY

IF13.4

2025-11-010

OAAI

miR-181d as a master-regulatory microRNA in glioblastomas that regulates RAD51 and MGMT expression to mediate acquired temozolomide resistance and cross-resistance to ionizing radiation

miR-181d作为胶质母细胞瘤中的主调控microRNA，通过调控RAD51和MGMT的表达来介导获得性替莫唑胺耐药以及对电离辐射的交叉耐药。

NEURO-ONCOLOGY

IF13.4

2025-11-010

OAAI

Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance

利用铁死亡来改变胶质母细胞瘤的治疗并克服治疗耐药性

Cell Death Discovery

IF7

2025-10-070

MODULATING POPULATIONAL VARIANCE OF METHYL-GUANINE METHYL TRANSFERASE (MGMT) EXPRESSION THROUGH MICRORNA DEGRADATION: A NOVEL MECHANISM OF TEMOZOLOMIDE RESISTANCE

NEURO-ONCOLOGY

IF13.4

2024-11-110

PRE

DIRECTIONALLY NON-ROTATING ELECTRIC FIELD THERAPY (DNEFT) DELIVERED THROUGH IMPLANTED ELECTRODES: A NOVEL SURGICAL PLATFORM FOR GLIOBLASTOMA IMMUNOTHERAPY

NEURO-ONCOLOGY

IF13.4

2024-11-110

PRE

Gut redox and microbiome: charting the roadmap to T-cell regulation

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-08-211

PRE

Directionally non-rotating electric field therapy delivered through implanted electrodes as a glioblastoma treatment platform: A proof-of-principle study

NEURO-ONCOLOGY ADVANCES

IF4.1

2024-07-130

OAAI

Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment

BIOMEDICINES

IF3.9

2023-09-2411

OAAI

Myricitrin from bayberry as a potential inhibitor of cathepsin-D: Prospects for squamous lung carcinoma prevention

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2023-09-012

PRE

Narirutin. A flavonoid found in citrus fruits modulates cell cycle phases and inhibits the proliferation of hormone-refractory prostate cancer cells by targeting hyaluronidase

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2023-04-0112

PRE

Isolation and characterization of a novel xanthone from the hairy root cultures of Swertia chirayita (Roxb.) H. Karst. and its biological activity

INDUSTRIAL CROPS AND PRODUCTS

IF6.2

2022-02-0112

PRE

Dietary flavonoid narirutin as a prospective antagonist of oncogenic pri/pre-microRNAs

PHYTOTHERAPY RESEARCH

IF6.3

2022-01-173

PRE

Flavonoid display ability to target microRNAs in cancer pathogenesis

BIOCHEMICAL PHARMACOLOGY

IF5.6

2021-07-0118

PREAI

Acacetin and pinostrobin as a promising inhibitor of cancer-associated protein kinases

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2021-05-0115

PREAI

Baicalin mediated regulation of key signaling pathways in cancer

PHARMACOLOGICAL RESEARCH

IF10.5

2021-02-01100

PREAI

Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2020-11-01146

PREAI

Cirsilineol inhibits proliferation of lung squamous cell carcinoma by inducing ROS mediated apoptosis

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2020-09-0127

PREAI

Rutin protects t-butyl hydroperoxide-induced oxidative impairment via modulating the Nrf2 and iNOS activity

PHYTOMEDICINE

IF8.3

2019-03-0160

PREAI

Antioxidant efficacy of chitosan/graphene functionalized superparamagnetic iron oxide nanoparticles

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

IF4.5

2018-09-2917

PREAI

Shilpi Singh

个人简介

教育背景

工作经历

荣誉奖项

研究方向